Fabry's disease natural history, complications and prognosis: Difference between revisions
Jose Loyola (talk | contribs) |
Jose Loyola (talk | contribs) |
||
| Line 2: | Line 2: | ||
If Fabry's disease leaves untreated it can lead to end-stage renal disease (ESRD), [[cardiomyopathy]], and [[stroke]] which are the main causes of death in these patients. Enzyme replacement therapy (ERT) treatment has an important role in their life expectancy and disease complications. | If Fabry's disease leaves untreated it can lead to end-stage renal disease (ESRD), [[cardiomyopathy]], and [[stroke]] which are the main causes of death in these patients. Enzyme replacement therapy (ERT) treatment has an important role in their life expectancy and disease complications. | ||
==Natural History | ==Natural History== | ||
__NOTOC__ | __NOTOC__ | ||
| Line 15: | Line 15: | ||
*The symptoms of late-onset Fabry's disease in females and atypical variants are accrue in higher ages and are less severe. | *The symptoms of late-onset Fabry's disease in females and atypical variants are accrue in higher ages and are less severe. | ||
*With out treatment, life span of heterozygote females will be at seventh decade and the main causes of death are cardiac dysfunction, cancer and stroke. | *With out treatment, life span of heterozygote females will be at seventh decade and the main causes of death are cardiac dysfunction, cancer and stroke. {{Cite book}}{{Cite book}}[1] | ||
==Complications== | ==Complications== | ||
Revision as of 17:56, 9 May 2022
Overview
If Fabry's disease leaves untreated it can lead to end-stage renal disease (ESRD), cardiomyopathy, and stroke which are the main causes of death in these patients. Enzyme replacement therapy (ERT) treatment has an important role in their life expectancy and disease complications.
Natural History
|
Fabry's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fabry's disease natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Fabry's disease natural history, complications and prognosis |
|
FDA on Fabry's disease natural history, complications and prognosis |
|
CDC on Fabry's disease natural history, complications and prognosis |
|
Fabry's disease natural history, complications and prognosis in the news |
|
Blogs on Fabry's disease natural history, complications and prognosis |
|
Risk calculators and risk factors for Fabry's disease natural history, complications and prognosis |
Homozygotes
- The symptoms of classic Fabry's disease usually develop in childhood or adolescents , and start with symptoms such as neuropathic pains, angiokeratomas, dyshidrosis, GI symptoms, and etc.
- Without treatment, lifespan of homozygote men will dramatically reduced to fifth decade and the main causes of deaths are renal failure, heart disease or stroke.
Heterozygote
- The symptoms of late-onset Fabry's disease in females and atypical variants are accrue in higher ages and are less severe.
- With out treatment, life span of heterozygote females will be at seventh decade and the main causes of death are cardiac dysfunction, cancer and stroke. Empty citation (help)Empty citation (help)[1]
Complications
- Common complications that can develop as a result of Fabry's disease are:
- Heart problems including cardiomyopathy, Arrhythmia, Heart failure
- Renal failure (ESRD)
- Peripheral neuropathy
- Strokes (such as TIA)
- Complications that can develop as a result of the treatment of Fabry's disease with enzyme replacement therapy are:
- Infusion reactions: rigors, fever, etc.
- Seroconversion: presents of anti-bodies may lower the efficacy of ERT.
Prognosis
- The prognosis of Fabry's disease improves with treatment. Without treatment, Fabry's disease will result in reduced life expectancy.
References
[1] 1-903539-03-XFabry, Hermann, et al. Fabry disease : perspectives from 5 years of FOS. Oxford: PharmaGenesis, 2006. Print.